FDA DEVICE FACTS
Magnetic Surgical System
Levita Magnetics International Corp
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Levita Magnetic Surgical System is designed to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy procedures; the liver in bariatric procedures; the prostate and periprostatic tissue in prostatectomy procedures; and the colon, rectum, and pericolorectal tissue in colorectal procedures to facilitate access and visualization of the surgical site. The device is indicated for use in patients with a BMI range of 20-60 kg/m2. Comparison of Intended Use, Indications for Use and Technological Characteristics with the Predicate Device: The subject and the predicate devices are identical in technological characteristics. The subject device differs from the predicate device by only a modification to the Indications for Use and the associated changes to the labeling. Results of animal testing demonstrated that the differences in the indications for use do not raise different questions of safety and effectiveness, and, therefore, the subject device has the same intended use as the predicate device. Comparison of Intended Use and Indications for Use Subject Device Predicate Device Intended Use To grasp, hold, retract, or manipulate soft tissue and organs. Same Indications for use The Magnetic Surgical System is designed to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy procedures; the liver in bariatric procedures; the prostate and periprostatic tissue in prostatectomy procedures; and the colon, pericolorectal tissue and adjacent organs in colorectal procedures to facilitate access and visualization of the The Magnetic Surgical System is designed to grasp and retract the body and the fundus of the gallbladder in laparoscopic cholecystectomy procedures, the liver in bariatric procedures, and the prostate and periprostatic tissue in prostatectomy procedures to facilitate access and visualization of the surgical site. The device is indicated for use in patients with a Page 2/5 Subject Device Predicate Device surgical site. The device is indicated for use in patients with a BMI range of 20- 60 kg/m2. BMI range of 20-60 kg/m2. The subject and predicate device share identical technological characteristics:
• Both devices are composed of two hand-held instruments: a Magnetic Grasper comprised of a detachable Grasper Tip and a Shaft, and an external Magnetic Controller.
• The principles of operation remain unchanged. For both devices, the Magnetic Grasper is actuated manually using the handle of the Shaft to grasp and release tissue; and the Grasper Tip is controlled manually by the handle or the external Magnetic Controller to retract tissue.
• The design, features and materials remain unchanged. As such, the design, materials and function of the subject Levita Magnetic Surgical System are substantially equivalent to the predicate Levita Magnetic Surgical System.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。